Eli Lilly and Company June 15th Short Interest Update

The short interest in Eli Lilly and Company (NYSE:LLY) has increased from 8,690,142 on May 31,2016 to 9,269,686 on June 15,2016. The change was measured at 579,544 shares or 6.7%. The leftover shorts were 1% of the floated shares. The days to cover are 3, given the average daily volume of 3,464,094 shares. The information was released by Financial Industry Regulatory Authority, Inc (FINRA) on June 24th after market close.

Eli Lilly and Company (NYSE:LLY): During Fridays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $72.45 and $71.87 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $75.12. The buying momentum continued till the end and the stock did not give up its gains. It closed at $74.33, notching a gain of 0.53% for the day. The total traded volume was 10,471,256 . The stock had closed at $73.94 on the previous day.

The company shares have dropped -11.28% from its 1 Year high price. On Sep 17, 2015, the shares registered one year high at $92.85 and the one year low was seen on Mar 17, 2016. The 50-Day Moving Average price is $74.87 and the 200 Day Moving Average price is recorded at $76.66.

Stocks of Eli Lilly and Company (NYSE:LLY) rallied by 0.64% during the past week but lost 0.88% on a 4-week basis. In the past week, the company has outperformed the S&P 500 by 2.31% and the outperformance has advanced to 2.12% for the last 4 weeks period.

Eli Lilly and Company (Lilly) is engaged in drug manufacturing business. The Company discovers, develops, manufactures and market products in two segments: human pharmaceutical products and animal health products. The Companys products are sold in approximately 120 countries. The Companys human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists. Its animal health business segment operates through the Companys Elanco division, which develops, manufactures and markets products for both food animals and companion animals. The Company manufactures and distributes its products through facilities in the United States, Puerto Rico and 11 other countries. Its products include endocrinology products, neuroscience products, oncology products, cardiovascular products, products for food animals, products for companion animals and Novartis AH products.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *